Cargando…

Identification of fusion genes in breast cancer by paired-end RNA-sequencing

BACKGROUND: Until recently, chromosomal translocations and fusion genes have been an underappreciated class of mutations in solid tumors. Next-generation sequencing technologies provide an opportunity for systematic characterization of cancer cell transcriptomes, including the discovery of expressed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edgren, Henrik, Murumagi, Astrid, Kangaspeska, Sara, Nicorici, Daniel, Hongisto, Vesa, Kleivi, Kristine, Rye, Inga H, Nyberg, Sandra, Wolf, Maija, Borresen-Dale, Anne-Lise, Kallioniemi, Olli
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091304/ https://www.ncbi.nlm.nih.gov/pubmed/21247443 http://dx.doi.org/10.1186/gb-2011-12-1-r6

Ejemplares similares

Reanalysis of RNA-Sequencing Data Reveals Several Additional Fusion Genes with Multiple Isoforms
por: Kangaspeska, Sara, et al.
Publicado: (2012)

Data integration from two microarray platforms identifies bi-allelic genetic inactivation of RIC8A in a breast cancer cell line
por: Muggerud, Aslaug Aamodt, et al.
Publicado: (2009)

Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response
por: Jernström, Sandra, et al.
Publicado: (2017)

High-Throughput 3D Screening Reveals Differences in Drug Sensitivities between Culture Models of JIMT1 Breast Cancer Cells
por: Hongisto, Vesa, et al.
Publicado: (2013)

Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer
por: Kangaspeska, Sara, et al.
Publicado: (2016)

The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells — A data description
por: Hongisto, Vesa, et al.
Publicado: (2014)

NMD Microarray Analysis for Rapid Genome-Wide Screen of Mutated Genes in Cancer
por: Wolf, Maija, et al.
Publicado: (2005)

Cytokinesis failure due to derailed integrin traffic induces aneuploidy and oncogenic transformation in vitro and in vivo
por: Högnäs, G, et al.
Publicado: (2012)

Gene expression profiling of human dermal fibroblasts exposed to bleomycin sulphate does not differentiate between radiation sensitive and control patients
por: Westbury, Charlotte B, et al.
Publicado: (2011)

Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication
por: Wolf, Maija, et al.
Publicado: (2010)

STRN-ALK rearranged pediatric malignant peritoneal mesothelioma – Functional testing of 527 cancer drugs in patient-derived cancer cells
por: Murumägi, Astrid, et al.
Publicado: (2021)

miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
por: Enerly, Espen, et al.
Publicado: (2011)

Correction: miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
por: Enerly, Espen, et al.
Publicado: (2013)

A new look towards BAC-based array CGH through a comprehensive comparison with oligo-based array CGH
por: Wicker, Nicolas, et al.
Publicado: (2007)

Association of tamoxifen resistance and lipid reprogramming in breast cancer
por: Hultsch, Susanne, et al.
Publicado: (2018)

Identifying In-Trans Process Associated Genes in Breast Cancer by Integrated Analysis of Copy Number and Expression Data
por: Aure, Miriam Ragle, et al.
Publicado: (2013)

MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro
por: Normann, Lisa Svartdal, et al.
Publicado: (2021)

Intrinsic resistance to PIM kinase inhibition in AML through p38α-mediated feedback activation of mTOR signaling
por: Brunen, Diede, et al.
Publicado: (2016)

Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors
por: Nunes-Xavier, Caroline E., et al.
Publicado: (2016)

High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma
por: Kohtamäki, Laura, et al.
Publicado: (2021)

High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer
por: Normann, Lisa Svartdal, et al.
Publicado: (2023)

miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
por: Lindholm, Evita Maria, et al.
Publicado: (2019)

Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors
por: Kolberg, Matthias, et al.
Publicado: (2017)

Circulating tumor DNA in early-stage breast cancer: personalized biomarkers for occult metastatic disease and risk of relapse?
por: af Hällström, Taija M, et al.
Publicado: (2015)

Advances in the genetics and epigenetics of gene regulation and human disease
por: Kleivi, Kristine
Publicado: (2006)

Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF
por: Tinholt, Mari, et al.
Publicado: (2015)

Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemness
por: Karvonen, Hanna, et al.
Publicado: (2020)

Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues
por: Kilpinen, Sami, et al.
Publicado: (2008)

Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies
por: Yadav, Bhagwan, et al.
Publicado: (2014)

Quantitative Multigene FISH on Breast Carcinomas Identifies der(1;16)(q10;p10) as an Early Event in Luminal A Tumors
por: Rye, Inga H, et al.
Publicado: (2015)

Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention
por: Raivola, Juuli, et al.
Publicado: (2022)

Amplified Loci on Chromosomes 8 and 17 Predict Early Relapse in ER-Positive Breast Cancers
por: Bilal, Erhan, et al.
Publicado: (2012)

DNA methylation at enhancers identifies distinct breast cancer lineages
por: Fleischer, Thomas, et al.
Publicado: (2017)

Mutations for the people
por: Kristensen, Vessela, et al.
Publicado: (2010)

Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer
por: Aure, Miriam Ragle, et al.
Publicado: (2015)

Intratumor heterogeneity defines treatment‐resistant HER2+ breast tumors
por: Rye, Inga H., et al.
Publicado: (2018)

A population‐based, retrospective cohort study of the association between ABO blood group and risk of COVID‐19
por: Dahlén, Torsten, et al.
Publicado: (2022)

Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study
por: Tinholt, Mari, et al.
Publicado: (2014)

Weather and biotic interactions as determinants of seasonal shifts in abundance measured through nest-box occupancy in the Siberian flying squirrel
por: Selonen, Vesa, et al.
Publicado: (2020)

FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data
por: Sboner, Andrea, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_05rktdcan3f0cts7gimaanq81l